Outcomes and costs within a disease management program for advanced congestive heart failure
Open Access
- 1 June 1998
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 135 (6) , S285-S292
- https://doi.org/10.1016/s0002-8703(98)70256-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Medical Care Costs and Quality of Life after Randomization to Coronary Angioplasty or Coronary Bypass SurgeryNew England Journal of Medicine, 1997
- Outcome of Acute Myocardial Infarction According to the Specialty of the Admitting PhysicianNew England Journal of Medicine, 1996
- The Role of Physicians in the Future of Quality ManagementNew England Journal of Medicine, 1996
- Improving the Quality of CareNew England Journal of Medicine, 1996
- Does Increased Access to Primary Care Reduce Hospital Readmissions?New England Journal of Medicine, 1996
- Costs and effects of enalapril therapy in patients with symptomatic heart failure: An economic analysis of the studies of left ventricular dysfunction (SOLVD) treatment trialJournal of Cardiac Failure, 1995
- Critical Pathways as a Strategy for Improving Care: Problems and PotentialAnnals of Internal Medicine, 1995
- A Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart FailureNew England Journal of Medicine, 1995
- Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial InfarctionNew England Journal of Medicine, 1995
- Epidemiology of heart failure in the United StatesAmerican Heart Journal, 1993